- Supported exchanges /
- F /
- 8F8.F
SYNACT PHARMA AB (8F8 F) stock market data APIs
SynAct Pharma AB, a clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden. The company develops AP1189, a drug candidate in Phase 2 clinical trial for the treatment of rheumatoid arthritis, idiopathic membranous nephropathy, and virus-induced respiratory insufficiency. It is developing TXP-11, an advanced peptide agonist that is in preclinical trials for the prevention of organ failure in surgery; and various drug programs to treat auto-immune and inflammatory diseases. SynAct Pharma AB was founded in 2012 and is headquartered in Lund, Sweden.
SYNACT PHARMA AB Financial Data Overview
| 0.7275 | |
| 0.721 | |
| - | |
| 0.7275 | |
| 0.7155 | |
| 0.534-1.336 | |
| 31 341 K | |
| 41 297 K | |
| 0 | |
| 0.684 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
SYNACT PHARMA AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -64 359 000
- Earnings Per Share -0.42
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get SYNACT PHARMA AB Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get SYNACT PHARMA AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
